Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 12, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares and American Depositary Receipts (ADRs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- March 8, 2007: Transfer of 15,312 Ordinary Shares.
- March 9, 2007: Transfer of 5,749 Ordinary Shares.
These transactions were advised to the company on March 12, 2007.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all current and former employees are potential beneficiaries. Consequently, three directors—Dr. J-P Garnier, Dr. M M Slaoui, and Mr. J S Heslop—hold an interest in the shares held by the trust in the same manner as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares transferred under the SmithKline Beecham Employee Share Option Plan 1991 (21,061 shares total).
- Confirm the specific dates of the transactions (March 8 and March 9, 2007).
- Note that this filing does not contain financial results; investors should refer to Form 20-F or other financial reports for performance metrics.